{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:53:29Z","timestamp":1773359609820,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"\n Purpose of review<\/jats:title>\n This review aims to update the studies involving the treatment of lower urinary tract symptoms (LUTS) in neurogenic patients, published in the last two years.<\/jats:p>\n <\/jats:sec>\n \n Recent findings<\/jats:title>\n Treatment of neurogenic LUTS (NLUTS) patients with \u03b23 adrenoreceptor agonists was investigated in real-life conditions. A randomized controlled trial compared the efficacy of antimuscarinics versus onabotulinum toxin A in neurogenic patients. The use of desmopressin to treat nocturia in multiple sclerosis patients is also reported. The long-term treatment with BontA efficacy, its discontinuation, and possible strategies to maintain patients on treatment were also evaluated. Sacral neuromodulation and tibial nerve stimulation are continuously being evaluated in neurogenic patients, especially in the last years.<\/jats:p>\n <\/jats:sec>\n \n Summary<\/jats:title>\n The management of urinary tract infections and vesical lithiasis, two common complications in NLUTS patients, and the management of both these patients was assessed in clinical trials.<\/jats:p>\n A trial evaluating the use of the anti-Nogo-A antibody after a spinal cord injury to facilitate neuronal rewiring and prevent or improve NLUTS was reported for the first time.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/mou.0000000000000774","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T17:44:36Z","timestamp":1589305476000},"page":"486-490","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of neurogenic lower urinary tract symptoms: main contributions from 2018 and 2019"],"prefix":"10.1097","volume":"30","author":[{"given":"Pedro","family":"Abreu-Mendes","sequence":"first","affiliation":[{"name":"Department of Urology, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o"},{"name":"Faculty of Medicine of Porto"}]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[{"name":"Department of Urology, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o"},{"name":"Faculty of Medicine of Porto"},{"name":"i3S Institute for Investigation and Innovation in Health, Porto, Portugal"}]},{"given":"Carlos","family":"Martins-Silva","sequence":"additional","affiliation":[{"name":"Department of Urology, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o"},{"name":"Faculty of Medicine of Porto"},{"name":"i3S Institute for Investigation and Innovation in Health, Porto, Portugal"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"eAO4207","DOI":"10.1590\/s1679-45082018ao4207","article-title":"Intradetrusor onabotulinumtoxin A injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, controlled, 24-week trial","volume":"16","author":"Ferreira","year":"2018","journal-title":"Einstein (Sao Paulo)"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-017-0216-4","article-title":"Real-life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin","volume":"17","author":"Tijnagel","year":"2017","journal-title":"BMC Urol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000500349","article-title":"Real-life data on mirabegron in neurogenic bladder dysfunction","volume":"103","author":"Soebadi","year":"2019","journal-title":"Urol Int"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1002\/nau.23774","article-title":"A pilot randomized controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction","volume":"37","author":"Welk","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.juro.2018.10.012","article-title":"Long-term discontinuation of botulinum toxin A intradetrusor injections for neurogenic detrusor overactivity: a multicenter study","volume":"201","author":"Baron","year":"2019","journal-title":"J Urol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/nau.23291","article-title":"Switch to abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of onabotulinum toxin A failed","volume":"37","author":"Bottet","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10286-018-0553-8","article-title":"Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder","volume":"30","author":"Tudor","year":"2020","journal-title":"Clin Auton Res"},{"key":"R8-20230918","first-page":"1","article-title":"Transcutaneous tibial nerve stimulation for treating neurogenic lower urinary tract dysfunction: a pilot study for an international multicenter randomized controlled trial","author":"Tornic","year":"2019","journal-title":"Eur Urol Focus"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.eururo.2017.01.037","article-title":"Persistence and adherence with mirabegron versus antimuscarinic agents in patients with overactive bladder: a retrospective observational study in UK clinical practice","volume":"72","author":"Chapple","year":"2017","journal-title":"Eur Urol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.juro.2014.01.027","article-title":"The validity and reliability of the neurogenic bladder symptom score","volume":"192","author":"Welk","year":"2014","journal-title":"J Urol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/nau.23921","article-title":"Desmopressin for treating nocturia in patients with multiple sclerosis: a systematic review: a report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS)","volume":"38","author":"Ph\u00e9","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.eururo.2017.12.031","article-title":"EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence","volume":"73","author":"Nambiar","year":"2018","journal-title":"Eur Urol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxin A in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnsys.2020.00001","article-title":"Transcutaneous electrical spinal cord neuromodulator (TESCoN) improves symptoms of overactive bladder","volume":"14","author":"Kreydin","year":"2020","journal-title":"Front Syst Neurosci"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00345-018-2345-0","article-title":"Surveillance and management of urologic complications after spinal cord injury","volume":"36","author":"Kreydin","year":"2018","journal-title":"World J Urol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/jac\/dkl010","article-title":"Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) program with a 2-year follow-up: an observational prospective study","volume":"57","author":"Salomon","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1473-3099(18)30279-2","article-title":"Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomized, open-label trial","volume":"18","author":"Fisher","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/nau.23859","article-title":"Effects of oral immunomodulation therapy on urinary tract infections in individuals with chronic spinal cord injury: a retrospective cohort study","volume":"38","author":"Krebs","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/nau.24091","article-title":"Outcomes of renal calculi in patients with spinal cord injury","volume":"38","author":"Lane","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sc.2017.46","article-title":"Influence of bladder lithiasis on lower urinary tract dynamics in patients with spinal cord injury","volume":"55","author":"V\u00edrseda-Chamorro","year":"2017","journal-title":"Spinal Cord"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1523\/JNEUROSCI.3155-18.2019","article-title":"Anti-Nogo-A antibodies as a potential causal therapy for lower urinary tract dysfunction after spinal cord injury","volume":"39","author":"Schneider","year":"2019","journal-title":"J Neurosci"}],"container-title":["Current Opinion in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOU.0000000000000774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T03:15:57Z","timestamp":1695006957000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOU.0000000000000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mou.0000000000000774","relation":{},"ISSN":["0963-0643","1473-6586"],"issn-type":[{"value":"0963-0643","type":"print"},{"value":"1473-6586","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}